Volatility seen in several vitamin markets

D-Calpan continues to be weak, although buyers now consider the potential impact of the container situation ex China and look at covering a bit forward into early Q2. The recent incident at a Chinese vitamin A production plant, together with less offers available from Western suppliers, has led to a slightly firmer market for vitamin A1000 and to some forward cover for the remainder of Q1 and some for early Q2. But no significant volatility seen so far. Vitamin D3 500, which is also produced